Alex Matthews

Endospan’s Nexus Aortic Arch Stent Graft System Approved by FDA | @EndospanLtd evtoday.com/news/endospans…

The best aortic valve also resides in his heart!!! OnX! heart-valve-surgery.com/videos/fred-ho… Long, active lives come from thoughtful, informed decisions. Congratulations, @CoachHoiberg!

I have never seen a patient with a failing aortic bioprosthesis placed with a “root enlargement” in the past whose coronaries were high enough to qualify them for a valve-in-valve TAVI.

@JordanBloomMD Thanks for sharing. Out of curiosity, which valve manufacturer was used in these cases?

Taking my second 19mm mechanical valve of the week out today for severe patient prosthesis mismatch and panus. Patients always report being told that mechanical valves last forever...

DUO

@AATSHQ Or use AMDS - 0 DANE through 2 years with AMDS, plus stable aortic dimensions & sustained true-lumen expansion enabling malperfusion resolution. Simple deployment and easy to implant.

Recently published in #JTCVS: A human cadaver study on the novel anastomotic device for the sandwich technique in type A aortic dissections. Read this Editor's Choice Article for free until 2/28 to see if the device is safe: doi.org/10.1016/j.jtcv…

Fantastic start to afternoon sessions learning from the masters about addressing aortic arch pathology @STS_CTsurgery #sts2026

Look who showed up on Jeopardy! last night. 😎👀

These studies remind me of tobacco company-sponsored studies in the 1950s that showed no early mortality differences between smokers and non-smokers.

Mark your calendars for an important webinar: Data-Driven Valve Selection for Younger AVR Patients, featuring @JordanBloomMD, @ChrisMalaisrie and @MarcGerdisch. September 25 at 8 am ET. Click here to register: bit.ly/4n4h4TP

Registration now open! Don’t miss this live webinar where experts will discuss the latest data on AVR, including the STS Database survival outcomes, On-X 5-year PAS results, and how valve selection is evolving for today’s patients. Register Here: ow.ly/9hKS50WPIc7

Congratulations to the @uabcvi Division of Cardiothoracic Surgery for earning the @STS_CTsurgery highest quality accreditation, a distinction that places UAB Medicine among the top 1% of cardiothoracic surgery programs nationwide.👏 🔗 brnw.ch/21wVrsQ

Mechanical valves are grossly underutilized in the US. There is a solid body of literature slowly emerging to back up this claim.

Incredible accomplishment! @UABCVI @Bamamd98 @clifton23526466 @KyleEudaileyMD @pannvar @RootGal210

Also amazing wetlab sponsored by @ArtivionInc a company truly dedicated to education and the Ross.

@PJSpen1982 Yes!! 🗣️

@georgetolisjr So true. What is also true is that half of pts getting bio-mitral valve will still need anticoagulation for afib or other indications. 1/3 pts getting bio-aortic valve will.

A bioprosthesis implanted on a young patient does not only expose them to the risk of a reoperation but more importantly to a second lifetime cycle of LV strain (aortic) or pulmonary hypertension (mitral) as well to development of endocarditis of the degenerated bioprosthesis.

@GeneralBuckTur2 @georgetolisjr On-X Aortic Valve managed at a low INR of 1.5-2.0 demonstrates an 87% reduction in major bleeding (MB) with no increase in thromboembolism (TE) and no valve thrombosis (VT) when compared to standard INR of 2.0-3.0. jtcvs.org/article/S0022-…

@georgetolisjr And so a mechanical prosthesis commits them to a lifelong anticoagulation and a noisy prosthesis that they can hear. The decision should be an informed discussion between patient and surgeon.

Acute Type A Dissection - What You Need to Know 2025 | AATS aats.org/events/acute-t…

jtcvsopen.org/article/S2666-… I hope everybody has seen this important study. Survival after TAVR was half compared to SAVR. If TAVR outcomes were better, this would clearly be published in @NEJM. Congratulations to the authors and @JTCVS. #TAVR is for the elderly…don’t drink the cool-aid. @AortaEd @MGHHeartHealth